What treatment regimen should be used for Helicobacter pylori eradication in patients with allergy to metronidazole or with allergy to fluoroquinolones (as the first choice and in case of initial treatment failure)?
High-dose amoxicillin–PPI dual therapy is cheaper and easy to perform. Can it be used as the first-choice regimen for Helicobacter pylori eradication in countries with high rates of bacterial resistance to clarithromycin?
What should be the management in a patient with 2 discordant H pylori test results (a negative stool antigen test and positive CLO test, or the other way round)?
If you were to name the 3 most important recent advances in gastroenterology that are relevant for everyday practice, what would they be?
Dr Pere Ginès shares his thoughts on the most important recent advance in the treatment of liver failure.
Dr Ian Gralnek from Technion-Israel Institute of Technology shares his views on the 3 most important recent advances in gastrointestinal endoscopy.
Dr Irene Sarosiek from Texas Tech University Health Sciences Center (TTUHSC), United States, offers her view on the 3 most important recent advances in the management of GI motility disorders.
Dr Paul Moayyedi, professor of medicine from McMaster University, shares his views on the 3 most important recent advances in gastroenterology.
Is fecal microbiota transplantation (FMT) going to be performed for indications other than Clostridium difficile infection (eg, alcoholic steatohepatitis, obesity, inflammatory bowel disease [IBD])?
Can the gut microbiota lead to diseases (eg, cirrhosis or obesity)?
English
Polski
Español
українська